Credit Suisse’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-16
| Closed | – | – | 4439 |
|
|
2022
Q2 | $0 | Buy |
+16
| New | – | ﹤0.01% | 4506 |
|
|
2021
Q4 | – | Sell |
-14,658
| Closed | -$124K | – | 3750 |
|
|
2021
Q3 | $124K | Buy |
14,658
+1,413
| +11% | +$12K | ﹤0.01% | 3440 |
|
|
2021
Q2 | $217K | Sell |
13,245
-11,124
| -46% | -$182K | ﹤0.01% | 3413 |
|
|
2021
Q1 | $538K | Sell |
24,369
-10,175
| -29% | -$225K | ﹤0.01% | 2911 |
|
|
2020
Q4 | $1.07M | Buy |
+34,544
| New | +$1.07M | ﹤0.01% | 2535 |
|